Facts, research and commentary on Australian health care

Updated 15 November 2026

Digital Health and Artificial Intelligence in Medical Practice – Readiness, Opportunity and Risk

by Stephen Milgate | Aug 12, 2026 | Technology

Artificial intelligence and broader digital health tools are transitioning from experimental applications to questions of system design, clinical workflow and regulatory readiness in Australia. The July 2026 release of the third National Policy Roadmap for AI in Healthcare, developed by the Australian Alliance for Artificial Intelligence in Healthcare with support from the Australian Institute of Health Innovation, the Digital Health Cooperative Research Centre, CSIRO’s Australian eHealth Research Centre and RMIT University, describes the Australian health system as insufficiently prepared for the pace of technological change. The roadmap calls for urgency and coordinated national action.

The roadmap sets out 28 recommendations across eight priority areas: leadership and governance, sovereign capability, workforce development, consumer engagement, industry development, research, and related enablers. Its central diagnosis is that rapid advances in generative and predictive AI have outpaced the development of coherent policy, regulation, data infrastructure and clinical readiness. Without deliberate action, Australia risks importing models poorly calibrated to local populations and clinical practice, exposing patients to unexamined risks, and missing opportunities to improve access, efficiency and outcomes.

Sovereign capability receives particular emphasis. The roadmap argues that Australia should develop sufficient technological independence, local expertise, infrastructure and governance to reduce reliance on international technology providers. Imported foundation models may perform less accurately on Australian demographic, disease and practice patterns. Data governance, continuity of service and regulatory leverage are all weakened when critical capability resides offshore. Recommendations include investment in Australian-controlled generative AI capabilities optimised for local healthcare needs and governed within Australia, alongside privacy-preserving techniques such as federated learning that allow model improvement without unnecessary centralisation of raw patient data.

Workforce readiness is another core theme. Clinicians will increasingly encounter AI tools for documentation support, image interpretation, risk prediction, triage assistance and, in limited domains, treatment recommendations. Safe and effective use requires understanding of model limitations, the ability to interrogate outputs, clear protocols for when human oversight is mandatory, and protection against deskilling. The roadmap stresses education and training across the continuum from undergraduate programs to continuing professional development. Parallel attention is needed for the non-clinical workforce that will implement, monitor and maintain these systems.

Consumer engagement and transparency form a further priority. Patients have a legitimate interest in knowing when AI is used in their care, what data underpin recommendations, and how decisions can be contested or overridden. Digital literacy varies widely across the population; tools that improve efficiency for digitally confident patients may widen disparities for others unless deliberately designed for equity. The integration of consumer-generated data from wearables and home monitoring devices adds another layer. Regulations expected by early 2027 will enable healthcare identifiers to be linked to wearable and biometric devices, bringing personal health data more formally into the national digital health infrastructure. This creates opportunities for continuous monitoring and earlier intervention, but also raises questions of consent, data quality, liability and the boundary between consumer wellness products and regulated medical devices.

Regulatory and governance gaps remain significant. Existing frameworks for medical devices, clinical decision support and professional standards were not designed for continuously learning or generative systems. Liability when an AI recommendation is followed or overridden, the validation of models on local data, post-market surveillance, and the management of bias and drift all require clearer rules. The roadmap recommends stronger national coordination, including consideration of a National AI in Healthcare Council or equivalent mechanism to harmonise oversight of safety, effectiveness, ethics and security. Research funding bodies have begun issuing guidance on the acceptable use of generative AI in grant applications and peer review, emphasising that human judgement must remain central; similar principles will need to be embedded in clinical governance.

Practical adoption is already visible. AI tools support administrative tasks, radiology and pathology image analysis, and some predictive risk models. Generative AI is being trialed for clinical documentation to reduce administrative burden — a significant contributor to clinician burnout. Yet the gap between pilot projects and system-wide safe deployment remains wide. Many health services lack the data infrastructure, interoperability, change-management capacity and clinical leadership required for reliable scaling. Privacy, cybersecurity and the risk of automation bias (over-reliance on algorithmic outputs) are recurring concerns in professional discussions.

Competing interests shape the trajectory. Technology vendors and some health service leaders emphasise efficiency gains, improved access in underserved areas, and the potential to shift care toward prevention and earlier intervention. Professional bodies and regulators prioritise safety, accountability and the preservation of clinical judgement. Privacy advocates and consumer groups highlight consent, data minimisation and the risk that commercial incentives may not align with patient interests. Governments face pressure both to encourage innovation and economic opportunity and to protect public trust in the health system. The independent evidence suggests that AI will not replace clinicians in the foreseeable future, but it will change the information environment in which clinical decisions are made and the workflows through which care is delivered.

The quality of outcomes will depend on deliberate choices: investment in local capability and data infrastructure; rigorous local validation of models; clear lines of clinical responsibility; transparent communication with patients; and sustained attention to equity so that digital tools do not exacerbate existing disparities in access or outcomes. Australia has an opportunity to shape AI adoption according to its own clinical standards, population needs and values rather than simply importing solutions developed elsewhere. The 2026 roadmap provides a detailed agenda. The test will be whether governments, professional bodies, industry and health services can move from diagnosis to coordinated implementation before the technology further outpaces the system’s capacity to govern it safely.

Sources

Disclaimer: The information provided on this website is general in nature only and does not constitute personal, financial, legal or medical advice. Before acting on any information on this website, you should consider the appropriateness of the information for your own objectives, financial situation and medical needs.